Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-06-09 Sale | 2025-06-10 5:00 pm | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 7,169 | $14.5 | $103,951 | 486,950 (Direct) | View |
| 2025-05-23 Sale | 2025-05-27 4:06 pm | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER | 2,146 | $11.31 | $24,272 | 173,026 (Direct) | View |
| 2025-05-23 Sale | 2025-05-27 4:05 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 1,926 | $11.31 | $21,782 | 135,689 (Direct) | View |
| 2025-05-22 Sale | 2025-05-23 4:26 pm | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER | 2,689 | $11.88 | $31,933 | 203,922 (Direct) | View |
| 2025-05-22 Sale | 2025-05-23 4:25 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 2,317 | $11.88 | $27,516 | 153,240 (Direct) | View |
| 2025-05-22 Sale | 2025-05-23 4:24 pm | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 9,999 | $11.88 | $118,743 | 655,368 (Direct) | View |
| 2025-05-19 Sale | 2025-05-20 7:28 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 2,600 | $11.84 | $30,791 | 107,513 (Direct) | View |
| 2025-05-19 Sale | 2025-05-20 7:28 pm | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 3,808 | $11.84 | $45,097 | 316,931 (Direct) | View |
| 2025-05-19 Sale | 2025-05-20 7:27 pm | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER | 2,776 | $11.84 | $32,876 | 124,342 (Direct) | View |
| 2025-04-09 Purchase | 2025-04-11 5:22 pm | KalVista Pharmaceuticals Inc. | KALV | Venrock Healthcare Capital Partners III L.P. VHCP Co-Investment Holdings III LLC VHCP Management EG LLC Venrock Healthcare Capital Partners EG L.P. VHCP Management III LLC Koh Bong Y Shah Nimish P 10% Owner | 25,000 | $9.42 | $235,500 | 5,303,985 (Indirect) | View |
| 2025-03-07 Sale | 2025-03-10 6:43 pm | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 6,669 | $11.97 | $79,828 | 475,312 (Direct) | View |
| 2025-02-24 Sale | 2025-02-25 8:37 pm | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER | 2,394 | $10.02 | $23,988 | 267,940 (Direct) | View |
| 2025-02-24 Sale | 2025-02-25 8:36 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 1,918 | $10.02 | $19,218 | 194,577 (Direct) | View |
| 2025-02-18 Sale | 2025-02-19 8:47 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 2,601 | $9.8242 | $25,553 | 108,906 (Direct) | View |
| 2025-02-18 Sale | 2025-02-19 8:46 pm | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER | 3,125 | $9.8242 | $30,701 | 124,512 (Direct) | View |
| 2025-02-18 Sale | 2025-02-19 8:46 pm | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 5,104 | $9.8242 | $50,143 | 311,783 (Direct) | View |
| 2025-02-12 Purchase | 2025-02-14 7:45 pm | KalVista Pharmaceuticals Inc. | KALV | Venrock Healthcare Capital Partners III L.P. VHCP Co-Investment Holdings III LLC VHCP Management EG LLC Venrock Healthcare Capital Partners EG L.P. VHCP Management III LLC Koh Bong Y Shah Nimish P 10% Owner | 161,700 | $9.2682 | $1,498,661 | 5,278,985 (Indirect) | View |
| 2025-02-07 Purchase | 2025-02-11 7:51 pm | KalVista Pharmaceuticals Inc. | KALV | Venrock Healthcare Capital Partners III L.P. VHCP Co-Investment Holdings III LLC VHCP Management EG LLC Venrock Healthcare Capital Partners EG L.P. VHCP Management III LLC Koh Bong Y Shah Nimish P 10% Owner | 104,489 | $9.2559 | $967,145 | 5,117,285 (Indirect) | View |
| 2025-01-30 Purchase | 2025-02-03 7:42 pm | KalVista Pharmaceuticals Inc. | KALV | Venrock Healthcare Capital Partners III L.P. VHCP Co-Investment Holdings III LLC VHCP Management EG LLC Venrock Healthcare Capital Partners EG L.P. VHCP Management III LLC Koh Bong Y Shah Nimish P 10% Owner | 70,023 | $8.8775 | $621,628 | 5,012,796 (Indirect) | View |
| 2024-12-09 Sale | 2024-12-09 9:08 pm | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 7,627 | $9.75 | $74,363 | 477,722 (Direct) | View |
| 2024-11-26 Sale | 2024-11-27 8:45 pm | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER | 2,187 | $9.8702 | $21,586 | 167,012 (Direct) | View |
| 2024-11-26 Sale | 2024-11-27 8:43 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 1,963 | $9.8718 | $19,378 | 134,892 (Direct) | View |
| 2024-11-18 Sale | 2024-11-19 7:19 pm | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 14,400 | $9.2565 | $133,294 | 308,889 (Direct) | View |
| 2024-11-18 Sale | 2024-11-19 7:18 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 7,192 | $9.2565 | $66,573 | 110,345 (Direct) | View |
| 2024-11-18 Sale | 2024-11-19 7:18 pm | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER | 8,077 | $9.2566 | $74,766 | 124,824 (Direct) | View |
| 2024-09-09 Sale | 2024-09-10 8:31 pm | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 7,352 | $12.19 | $89,622 | 469,551 (Direct) | View |
| 2024-08-23 Sale | 2024-08-26 8:00 pm | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER | 2,135 | $12.4 | $26,474 | 158,745 (Direct) | View |
| 2024-08-23 Sale | 2024-08-26 7:58 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 1,916 | $12.4 | $23,758 | 132,551 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-06-06 Exercise | 2025-06-10 5:00 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 15,625 | $0 | 486,950 (Direct) | View |
| 2025-05-22 Exercise | 2025-05-27 4:06 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER | 5,000 | $0 | 173,026 (Direct) | View |
| 2025-05-22 Exercise | 2025-05-27 4:05 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 3,125 | $0 | 135,689 (Direct) | View |
| 2025-05-21 Exercise | 2025-05-23 4:26 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER | 6,250 | $0 | 203,922 (Direct) | View |
| 2025-05-21 Exercise | 2025-05-23 4:25 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 3,750 | $0 | 153,240 (Direct) | View |
| 2025-05-21 Exercise | 2025-05-23 4:24 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 23,250 | $0 | 655,368 (Direct) | View |
| 2025-05-17 Exercise | 2025-05-20 7:28 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 8,410 | $0 | 107,513 (Direct) | View |
| 2025-05-17 Exercise | 2025-05-20 7:28 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 18,728 | $0 | 316,931 (Direct) | View |
| 2025-05-17 Exercise | 2025-05-20 7:27 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER | 12,894 | $0 | 124,342 (Direct) | View |
| 2025-03-06 Exercise | 2025-03-10 6:43 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 15,625 | $0 | 475,312 (Direct) | View |
| 2025-02-22 Exercise | 2025-02-25 8:37 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER | 5,000 | $0 | 267,940 (Direct) | View |
| 2025-02-21 Option Award | 2025-02-25 8:37 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER | 100,000 | $0 | 267,940 (Direct) | View |
| 2025-02-21 Option Award | 2025-02-25 8:36 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 372,000 | $0 | 372,000 (Direct) | View |
| 2025-02-22 Exercise | 2025-02-25 8:36 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 3,125 | $0 | 194,577 (Direct) | View |
| 2025-02-21 Option Award | 2025-02-25 8:36 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 60,000 | $0 | 194,577 (Direct) | View |
| 2025-02-21 Option Award | 2025-02-25 8:35 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Piekos Brian Chief Financial Officer | 80,000 | $0 | 80,000 (Direct) | View |
| 2025-02-17 Exercise | 2025-02-19 8:47 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 8,408 | $0 | 108,906 (Direct) | View |
| 2025-02-17 Exercise | 2025-02-19 8:46 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER | 12,894 | $0 | 124,512 (Direct) | View |
| 2025-02-17 Exercise | 2025-02-19 8:46 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 18,726 | $0 | 311,783 (Direct) | View |
Ownership | 2025-02-03 7:39 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Venrock Healthcare Capital Partners III L.P. VHCP Co-Investment Holdings III LLC VHCP Management III LLC Venrock Healthcare Capital Partners EG L.P. VHCP Management EG LLC Koh Bong Y Shah Nimish P 10% Owner | 0 | $0 | 5,598,511 (Indirect) | View |
| 2024-12-06 Exercise | 2024-12-09 9:08 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 15,625 | $0 | 477,722 (Direct) | View |
| 2024-11-22 Exercise | 2024-11-27 8:45 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER | 5,000 | $0 | 167,012 (Direct) | View |
| 2024-11-22 Exercise | 2024-11-27 8:43 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 3,125 | $0 | 134,892 (Direct) | View |
| 2024-11-23 Option Award | 2024-11-26 4:41 pm | N/A 2034-11-22 | KalVista Pharmaceuticals Inc. | KALV | Reid Laurence Director | 17,000 | $0 | 17,000 (Direct) | View |
| 2024-11-17 Exercise | 2024-11-19 7:19 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 60,396 | $0 | 308,889 (Direct) | View |
| 2024-11-17 Exercise | 2024-11-19 7:18 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 22,992 | $0 | 110,345 (Direct) | View |
| 2024-11-17 Exercise | 2024-11-19 7:18 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER | 37,062 | $0 | 124,824 (Direct) | View |
| 2024-10-03 Option Award | 2024-10-04 4:08 pm | N/A 2034-10-02 | KalVista Pharmaceuticals Inc. | KALV | Fairey William Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2024-10-03 Option Award | 2024-10-04 4:08 pm | N/A 2034-10-02 | KalVista Pharmaceuticals Inc. | KALV | Pereira Brian JG Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2024-10-03 Option Award | 2024-10-04 4:07 pm | N/A 2034-10-02 | KalVista Pharmaceuticals Inc. | KALV | Stuart Nancy Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2024-10-03 Option Award | 2024-10-04 4:07 pm | N/A 2034-10-02 | KalVista Pharmaceuticals Inc. | KALV | Treanor Patrick Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2024-10-03 Option Award | 2024-10-04 4:06 pm | N/A 2034-10-02 | KalVista Pharmaceuticals Inc. | KALV | Unkart Edward W Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2024-09-09 Option Award | 2024-09-11 4:34 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Piekos Brian Chief Financial Officer | 100,000 | $0 | 100,000 (Direct) | View |
| 2024-09-06 Exercise | 2024-09-10 8:31 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 15,625 | $0 | 469,551 (Direct) | View |
| 2024-08-22 Exercise | 2024-08-26 8:00 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER | 5,000 | $0 | 158,745 (Direct) | View |
| 2024-08-22 Exercise | 2024-08-26 7:58 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 3,125 | $0 | 132,551 (Direct) | View |